Showing results (1951-1960 of 10,003) with videos related to
Sort By:
Pageof 1,001
Leukemia & Lymphoma|October 26, 2020
Lower vancomycin trough levels in adults undergoing unrelated cord blood transplantationTakeo Yasu, Takaaki Konuma, Maki Oiwa-Monna, et al.Leukemia & Lymphoma|October 27, 2020
Herpes zoster during arsenic trioxide therapy for acute promyelocytic leukemiaCraig W Freyer, Chelsea E Peterson, Yun Man, et al.Leukemia & Lymphoma|October 28, 2020
LAG-3 is expressed on a majority of tumor infiltrating lymphocytes in pediatric Hodgkin lymphomaScott Moerdler, Michelle Ewart, Debra L Friedman, et al.Leukemia & Lymphoma|October 28, 2020
Efficacy and safety of weekly carfilzomib (70 mg/m2), dexamethasone, and daratumumab (KdD70) is comparable to twice-weekly KdD56 while being a more convenient dosing option: a cross-study comparison of the CANDOR and EQUULEUS studiesXavier Leleu, Meral Beksac, Takaaki Chou, et al.Leukemia & Lymphoma|October 6, 2020
Dasatinib treatment long-term results among imatinib-resistant/intolerant patients with chronic phase chronic myeloid leukemia are favorable in daily clinical practiceDaniela Zackova, Hana Klamova, Petra Belohlavkova, et al.Leukemia & Lymphoma|October 7, 2020
Pralatrexate in relapsed/refractory T-cell lymphoma: a retrospective multicenter studyMansi Bhurani, Lorenz Admojo, Carrie Van Der Weyden, et al.Leukemia & Lymphoma|October 12, 2020
Effects of azacitidine in 93 patients with IDH1/2 mutated acute myeloid leukemia/myelodysplastic syndromes: a French retrospective multicenter studyC Willekens, R Rahme, M Duchmann, et al.Leukemia & Lymphoma|November 28, 2018
Differentiating factors in treatment-free remission trials: impact of study design on results and clinical applicationsEllen K RitchieLeukemia & Lymphoma|January 17, 2019
Outcome and prognosis of anaplastic large cell lymphoma in children: a report from the Taiwan Pediatric Oncology GroupShih-Hsiang Chen, Jiann-Shiuh Chen, Shiann-Tarng Jou, et al.Leukemia & Lymphoma|December 1, 2018
Dichotomization of the new revised international prognostic scoring system for a better clinical stratification of patients with myelodysplastic syndromesJulia Montoro, Helena Pomares, Guillermo Villacampa, et al.Pageof 1,001